ARCHIVES

Phase II Study Finds Dasatinib May Overcome ALL Resistance

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

Harvest Yet To Come From Radiotherapy Advances, Kaplan Tells NCAB

October 17, 1975

In Brief: Ireland Cancer Center Named Comprehensive; UPCI Appoints Four Program Directors

February 27, 1998

Rauscher To Become ACS VP For Research Nov. 1; Search Starts for New NCI Director

September 24, 1976

Cancer Trials Take 800 Days To Start On Average; NCI Vows Improvement.

April 11, 2008

Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting

June 20, 1986

NCI Supports New Cervical Cancer Screening Guideline

January 31, 2003